An aqueous ink for ink jet, the aqueous ink containing a pigment and a resin. The pigment is impregnated with a compound having a structure in which at least two structures each represented by General Formula (1) are bonded by a glycoside bond.

##STR00001##

An aqueous ink for ink jet, the aqueous ink containing a pigment and a resin. The pigment is impregnated with a compound having a structure in which at least two structures each represented by General Formula (1) are bonded by a glycoside bond.

##STR00001##

An aqueous dispersion of a capsule is composed of a polymeric shell surrounding a core, the core containing an oligomeric blocked isocyanate characterized in that the blocked isocyanate is derived from a di-, tri- or tetrafunctional isocyanate terminated oligomer selected from the group of an isocyanate terminated oligo-ether, an isocyanate terminated oligo-ester, an isocyanate terminated oligo-carbonate, an isocyanate terminated butadiene oligomer, an isocyanate terminated hydrogenated butadiene, an isocyanate terminated isoprene oligomer, an isocyanate terminated silicone and combinations thereof. The dispersion is suitable for pre-treatment liquids and inkjet inks in textile printing.

An aqueous dispersion of a capsule is composed of a polymeric shell surrounding a core, the core containing an oligomeric blocked isocyanate characterized in that the blocked isocyanate is derived from a di-, tri- or tetrafunctional isocyanate terminated oligomer selected from the group of an isocyanate terminated oligo-ether, an isocyanate terminated oligo-ester, an isocyanate terminated oligo-carbonate, an isocyanate terminated butadiene oligomer, an isocyanate terminated hydrogenated butadiene, an isocyanate terminated isoprene oligomer, an isocyanate terminated silicone and combinations thereof. The dispersion is suitable for pre-treatment liquids and inkjet inks in textile printing.

The present invention is directed to an ultraviolet curing ink jet ink composition which contains at least a polymerizable compound and a photopolymerization initiator, and is free from an aqueous solvent. The polymerizable compound comprises at least a urethane oligomer, and the photopolymerization initiator comprises an acylphosphineoxide and α-hydroxyketone. The polymerizable compound further comprises an allyl compound and/or an N-vinyl compound.

The present invention is directed to an ultraviolet curing ink jet ink composition which contains at least a polymerizable compound and a photopolymerization initiator, and is free from an aqueous solvent. The polymerizable compound comprises at least a urethane oligomer, and the photopolymerization initiator comprises an acylphosphineoxide and α-hydroxyketone. The polymerizable compound further comprises an allyl compound and/or an N-vinyl compound.

Polyurethanes containing at least one bisphosphonate group, as well as related compositions, articles, and methods, are disclosed.

Polyurethanes containing at least one bisphosphonate group, as well as related compositions, articles, and methods, are disclosed.

The invention comprises a novel modular, generalizable meso-micro-nano-fluidic platform apparatus, design and methodology which in exemplary embodiments may be applied in conjunction with a novel external triggering and automation/feedback loop control mechanism deployed via computer to explore the phase space of single or double emulsification for applications including the encapsulation of hydrophilic active pharmacological ingredients (APIs). End use applications include the mass production of particulate encapsulation of hydrophobic or hydrophilic APIs with automatic or user-supervised feedback methodology to control and discover mass production or per-drug customized settings of interest for the manufacture of novel or extant therapeutics. This invention allows for a process to produce monodispersed particles of varying sizes and may be used to rapidly screen for optimal size for maximal bioavailability of API particles either on lab bench for in vitro dissolution or in vivo studies, and patient-specific handhelds for maximal drug inhalation.

The invention comprises a novel modular, generalizable meso-micro-nano-fluidic platform apparatus, design and methodology which in exemplary embodiments may be applied in conjunction with a novel external triggering and automation/feedback loop control mechanism deployed via computer to explore the phase space of single or double emulsification for applications including the encapsulation of hydrophilic active pharmacological ingredients (APIs). End use applications include the mass production of particulate encapsulation of hydrophobic or hydrophilic APIs with automatic or user-supervised feedback methodology to control and discover mass production or per-drug customized settings of interest for the manufacture of novel or extant therapeutics. This invention allows for a process to produce monodispersed particles of varying sizes and may be used to rapidly screen for optimal size for maximal bioavailability of API particles either on lab bench for in vitro dissolution or in vivo studies, and patient-specific handhelds for maximal drug inhalation.